Turku, Finland

Jouko Jalonen

This inventor holds 1 USPTO granted patent. Top assignee: Ge Healthcare Finland Oy. Active years: 2007.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jouko Jalonen: Innovator in Predictive Healthcare Technology

Introduction

Jouko Jalonen is a notable inventor based in Turku, Finland. He has made significant contributions to the field of healthcare technology, particularly in predicting perioperative myocardial ischemia. His innovative approach combines heart rate measurements with advanced analytical techniques to enhance patient outcomes.

Latest Patents

Jouko Jalonen holds a patent for a method and arrangement for predicting perioperative myocardial ischemia. This patent involves conducting heart rate measurements before surgical operations to gather essential heart rate data. The data is then analyzed using a device configured for heart rate variability analysis (HRV). By employing fractal analysis, the method examines the fractal correlation properties of the heart rate data, revealing significant variations between night-time and day-time measurements.

Career Highlights

Jouko Jalonen is associated with GE Healthcare Finland Oy, where he applies his expertise in healthcare technology. His work focuses on improving predictive methods that can lead to better management of patient care during surgical procedures.

Collaborations

Jouko has collaborated with notable colleagues, including Timo Laitio and Harry Scheinin. Their combined efforts contribute to advancements in healthcare technology and patient safety.

Conclusion

Jouko Jalonen's innovative work in predictive healthcare technology exemplifies the impact of inventions on improving patient outcomes. His contributions continue to shape the future of medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…